286 related articles for article (PubMed ID: 26732365)
1. Cobaltoceniumethynyl gold(I) as an unusual heterodinuclear bioorganometallic fragment to study the biological properties of alkynyl gold complexes.
Vanicek S; Kopacka H; Wurst K; Vergeiner S; Kankowski S; Schur J; Bildstein B; Ott I
Dalton Trans; 2016 Jan; 45(4):1345-8. PubMed ID: 26732365
[TBL] [Abstract][Full Text] [Related]
2. Gold(I) thiotetrazolates as thioredoxin reductase inhibitors and antiproliferative agents.
Serebryanskaya TV; Lyakhov AS; Ivashkevich LS; Schur J; Frias C; Prokop A; Ott I
Dalton Trans; 2015 Jan; 44(3):1161-9. PubMed ID: 25413270
[TBL] [Abstract][Full Text] [Related]
3. Gold(I) N-heterocyclic carbene complexes with naphthalimide ligands as combined thioredoxin reductase inhibitors and DNA intercalators.
Meyer A; Oehninger L; Geldmacher Y; Alborzinia H; Wölfl S; Sheldrick WS; Ott I
ChemMedChem; 2014 Aug; 9(8):1794-800. PubMed ID: 24803348
[TBL] [Abstract][Full Text] [Related]
4. Metal complexes of 3-(4-bromophenyl)-1-pyridin-2-ylprop-2-en-1-one thiosemicarbazone: cytotoxic activity and investigation on the mode of action of the gold(III) complex.
Sâmia LB; Parrilha GL; Da Silva JG; Ramos JP; Souza-Fagundes EM; Castelli S; Vutey V; Desideri A; Beraldo H
Biometals; 2016 Jun; 29(3):515-26. PubMed ID: 27091443
[TBL] [Abstract][Full Text] [Related]
5. Cationic and Neutral N-Heterocyclic Carbene Gold(I) Complexes: Cytotoxicity, NCI-60 Screening, Cellular Uptake, Inhibition of Mammalian Thioredoxin Reductase, and Reactive Oxygen Species Formation.
Zhang C; Hemmert C; Gornitzka H; Cuvillier O; Zhang M; Sun RW
ChemMedChem; 2018 Jun; 13(12):1218-1229. PubMed ID: 29603648
[TBL] [Abstract][Full Text] [Related]
6. Benzimidazol-2-ylidene gold(I) complexes are thioredoxin reductase inhibitors with multiple antitumor properties.
Rubbiani R; Kitanovic I; Alborzinia H; Can S; Kitanovic A; Onambele LA; Stefanopoulou M; Geldmacher Y; Sheldrick WS; Wolber G; Prokop A; Wölfl S; Ott I
J Med Chem; 2010 Dec; 53(24):8608-18. PubMed ID: 21082862
[TBL] [Abstract][Full Text] [Related]
7. Gold(I) NHC Complexes: Antiproliferative Activity, Cellular Uptake, Inhibition of Mammalian and Bacterial Thioredoxin Reductases, and Gram-Positive Directed Antibacterial Effects.
Schmidt C; Karge B; Misgeld R; Prokop A; Franke R; Brönstrup M; Ott I
Chemistry; 2017 Feb; 23(8):1869-1880. PubMed ID: 27865002
[TBL] [Abstract][Full Text] [Related]
8. Potent Inhibition of Thioredoxin Reductase by the Rh Derivatives of Anticancer M(arene/Cp*)(NHC)Cl
Truong D; Sullivan MP; Tong KKH; Steel TR; Prause A; Lovett JH; Andersen JW; Jamieson SMF; Harris HH; Ott I; Weekley CM; Hummitzsch K; Söhnel T; Hanif M; Metzler-Nolte N; Goldstone DC; Hartinger CG
Inorg Chem; 2020 Mar; 59(5):3281-3289. PubMed ID: 32073260
[TBL] [Abstract][Full Text] [Related]
9. NHC gold halide complexes derived from 4,5-diarylimidazoles: synthesis, structural analysis, and pharmacological investigations as potential antitumor agents.
Liu W; Bensdorf K; Proetto M; Abram U; Hagenbach A; Gust R
J Med Chem; 2011 Dec; 54(24):8605-15. PubMed ID: 22091836
[TBL] [Abstract][Full Text] [Related]
10. Gold(I) and Gold(III) N-Heterocyclic Carbene Complexes as Antibacterial Agents and Inhibitors of Bacterial Thioredoxin Reductase.
Büssing R; Karge B; Lippmann P; Jones PG; Brönstrup M; Ott I
ChemMedChem; 2021 Nov; 16(22):3402-3409. PubMed ID: 34268875
[TBL] [Abstract][Full Text] [Related]
11. Current Progresses in Metal-based Anticancer Complexes as Mammalian TrxR Inhibitors.
Cheng Y; Qi Y
Anticancer Agents Med Chem; 2017; 17(8):1046-1069. PubMed ID: 28270080
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Thioredoxin Reductase by Triosmium Carbonyl Clusters.
Koh WX; Coppo L; Holmgren A; Kong JW; Leong WK
Chem Res Toxicol; 2020 Sep; 33(9):2441-2445. PubMed ID: 32786549
[TBL] [Abstract][Full Text] [Related]
13. Exploring the C^N^C theme: Synthesis and biological properties of tridentate cyclometalated gold(III) complexes.
Jürgens S; Scalcon V; Estrada-Ortiz N; Folda A; Tonolo F; Jandl C; Browne DL; Rigobello MP; Kühn FE; Casini A
Bioorg Med Chem; 2017 Oct; 25(20):5452-5460. PubMed ID: 28823538
[TBL] [Abstract][Full Text] [Related]
14. Comparative in vitro evaluation of N-heterocyclic carbene gold(I) complexes of the benzimidazolylidene type.
Rubbiani R; Can S; Kitanovic I; Alborzinia H; Stefanopoulou M; Kokoschka M; Mönchgesang S; Sheldrick WS; Wölfl S; Ott I
J Med Chem; 2011 Dec; 54(24):8646-57. PubMed ID: 22039997
[TBL] [Abstract][Full Text] [Related]
15. Alkynyl gold(I) phosphane complexes: Evaluation of structure-activity-relationships for the phosphane ligands, effects on key signaling proteins and preliminary in-vivo studies with a nanoformulated complex.
Andermark V; Göke K; Kokoschka M; Abu El Maaty MA; Lum CT; Zou T; Sun RW; Aguiló E; Oehninger L; Rodríguez L; Bunjes H; Wölfl S; Che CM; Ott I
J Inorg Biochem; 2016 Jul; 160():140-8. PubMed ID: 26850306
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of curcumin analogues as potential thioredoxin reductase inhibitors.
Qiu X; Liu Z; Shao WY; Liu X; Jing DP; Yu YJ; An LK; Huang SL; Bu XZ; Huang ZS; Gu LQ
Bioorg Med Chem; 2008 Sep; 16(17):8035-41. PubMed ID: 18678491
[TBL] [Abstract][Full Text] [Related]
17. Metal complexes with 2-acetylpyridine-N(4)-orthochlorophenylthiosemicarbazone: cytotoxicity and effect on the enzymatic activity of thioredoxin reductase and glutathione reductase.
Parrilha GL; Ferraz KS; Lessa JA; de Oliveira KN; Rodrigues BL; Ramos JP; Souza-Fagundes EM; Ott I; Beraldo H
Eur J Med Chem; 2014 Sep; 84():537-44. PubMed ID: 25058344
[TBL] [Abstract][Full Text] [Related]
18. On the biological properties of alkynyl phosphine gold(I) complexes.
Meyer A; Bagowski CP; Kokoschka M; Stefanopoulou M; Alborzinia H; Can S; Vlecken DH; Sheldrick WS; Wölfl S; Ott I
Angew Chem Int Ed Engl; 2012 Aug; 51(35):8895-9. PubMed ID: 22848030
[No Abstract] [Full Text] [Related]
19. Synthesis and characterization of azolate gold(I) phosphane complexes as thioredoxin reductase inhibiting antitumor agents.
Galassi R; Burini A; Ricci S; Pellei M; Rigobello MP; Citta A; Dolmella A; Gandin V; Marzano C
Dalton Trans; 2012 May; 41(17):5307-18. PubMed ID: 22391922
[TBL] [Abstract][Full Text] [Related]
20. De novo design of thioredoxin reductase-targeted heterometallic titanocene-gold compounds of chlorambucil for mechanistic insights into renal cancer.
Tabrizi L; Olasunkanmi LO; Fadare OA
Chem Commun (Camb); 2019 Dec; 56(2):297-300. PubMed ID: 31808475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]